- Recommendation ID
- NG242/4
- Question
In people experiencing a rapid, substantial reduction in HbA1c, what is the risk of short-term progression of diabetic retinopathy or diabetic macular oedema, and is there a risk of long-term visual loss?
- Any explanatory notes
(if applicable) For a short explanation of why the committee made this recommendation for research, see the rationale section on effects of a rapid reduction in HbA1c
Full details of the evidence and the committee's discussion are in evidence review C: effectiveness of intensive treatments to lower blood glucose levels.
Source guidance details
- Comes from guidance
- Diabetic retinopathy: management and monitoring
- Number
- NG242
- Date issued
- August 2024
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 28/01/2025 |